Engineering small‐molecule analogues of altiratinib via CREB‐regulated transcription co‐activator 3‐target screening for the development of potent and safe topical therapeutics against skin hyperpigmentary diseases

Authors:

Abstract
No abstract available
Funding Information
  • National Research Foundation of Korea (2020R1A4A4079708, RS‐2023‐00208426, RS‐2023‐00246165)

This publication has 10 references indexed in Scilit: